Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-26

Clinical Trial Update: Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and immunogenicity of a DNA-based Venezuelan equine encephalitis virus vaccine delivered by electroporation in healthy volun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VEE DNA vaccine (Venezuelan equine encephalitis virus) (DNA vaccine encoding VEEV antigens)

Snippet

Sponsor: Ichor Medical Systems Incorporated | Conditions: Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Status: COMPLETED